ESR1 and breast carcinoma: On the other hand, ER+ breast cancer cells are not as malignant, and, in addition, the patterns of their malignancy are usually simpler than those of ER- cells, which may be the reason why the miR-34b expression pattern in ER+ cancer patients is more consistent and more important than that in ER- cancer patients.